Skip to content
Aperlena
Free alerts

Germany - Pharmaceuticals - Discount agreement under Section 130a(8) SGB V in conjunction with Section 130c(1) SGB V for the medicinal product Factor VIII SDH (B02BD02) for the treatment of haemophilia

Original Deutschland - Arzneimittel - Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu dem Arzneimittel Faktor VIII SDH (B02BD02) zur Behandlung der Hämophilie

Awarded Contract award

Key facts

Winner
Intersero GmbH
Buyer
AOK Sachsen - Anhalt
Where
Germany
Procedure
Negotiated procedure The buyer selects candidates, then negotiates the offers before choosing. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
German
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 2 weeks ago
Notice number
606717-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Published
  2. Awarded pending

Summary

Machine-generated summary

AOK Sachsen-Anhalt concluded a discount agreement under Section 130a(8) SGB V in conjunction with Section 130c(1) SGB V with the manufacturer of the medicinal product Factor VIII SDH (B02BD02), used to treat haemophilia. The contract took effect on 01.09.2026. The contract covers the agreement of discounts on the finished medicinal product Factor VIII SDH (B02BD02) of the contractor, settled at the expense of AOK Sachsen-Anhalt during the contract term on the currently valid prescription form. The contract was awarded to Intersero GmbH. The status of the procedure is contract awarded.

Description

Die AOK Sachsen-Anhalt hat zur Behandlung der Hämophilie mit dem Hersteller des Arzneimittel Faktor VIII SDH (B02BD02) zum 01.09.2026 einen Vertrag gem. § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V abgeschlossen. Gegenstand dieses Vertrages ist die Vereinbarung von Rabatten gemäß § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V für das Fertigarzneimittel Faktor VIII SDH (B02BD02) des Auftragnehmers, die während der Vertragslaufzeit zu Lasten der Auftraggeberin auf dem jeweils gültigen Arzneiverordnungsblatt ( z.B. Muster 16 oder Muster e16A der Vordruckvereinbarung bzw. der Vordruckvereinbarung digitale Vordrucke zum BMV-Ä) abgerechnet werden.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 weeks ago

View the official notice

More from this buyer

Full buyer profile

56 open tenders right now

Recent awards

Similar tenders

2

days left

New · Defibrillator HKL7

Germany Medical equipment & pharmaceuticals Universitätsklinikum Düsseldorf

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,085,809
9,975 open across Europe right now
Buyer track record on Aperlena
93 notices tracked · 36 awarded
€2,700,013 in awarded contracts

Never miss a tender like this

71 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language